• About
  • Advertise
  • Careers
  • Write for us
  • Contact
  • Terms of service
Sunday, June 26, 2022
The Millennial Source
TMS
Home WORLD

California lab discovers coronavirus vaccine in record time

byDhipa Palani
February 14, 2020
in WORLD
Source: Fox Business

Source: Fox Business

Share on FacebookShare on TwitterShare on Linkedin



Using an algorithm designed at their laboratory, biotechnology company Inovio Pharmaceuticals claims to have discovered a vaccine to combat the Wuhan coronavirus (COVID-19) in only three hours.

“We have an algorithm, which we designed, and we put the DNA sequence into our algorithm and came up with the vaccine in that short amount of time,” said Dr. Trevor Smith, director of research and development at Inovio. 

According to researchers at the lab in San Diego in the United States, they have the infrastructure and expertise to find the vaccine. The vaccine has so far been tested on animals and will be available for clinical trials in a few months, possibly in the northern hemisphere summer months, which is considered to be a record time for testing to be made available to humans. 

The California-based lab had also developed vaccines for the Zika virus, the Middle East respiratory syndrome (MERS) and Ebola.

Promising new vaccine 

On January 9, Chinese scientists released the genetic sequence of the new coronavirus and researchers around the world have been scrambling to find a vaccine for it. 

According to a senior scholar at the independent, nonprofit organization, Johns Hopkins Center for Health Security, Dr. Amesh Adalja, given the technology and infrastructure of Inovio, scientists are positive the vaccine could be a viable option to tackling the deadly coronavirus which has killed more than 1,383 people so far as of February 14.

“I think it’s very promising, and Inovio has very advanced technology that they’re using with making a DNA vaccine, which is different than our traditional vaccines,” Dr. Adalja told CBS News. 

Source: CPHI

Collaboration with China 

Inovio collaborated with China’s Beijing Advaccine Biotechnology Co. to develop a vaccine with an initial grant of US$9 million funded by the Coalition for Epidemic Preparedness Innovations (CEPI), a public-private coalition headquartered in Norway that aims to speed up the development of vaccines. The collaboration will allow the US-based lab to enter China and deliver the new vaccine (named the INO-4800) to much-needed areas as soon as possible. 

After the collaboration was announced, Inovio stock surged by 12%.   

Besides Inovio, other pharmaceutical firms in the US have entered into collaborations with Chinese labs. US biotech giant, Gilead Sciences, has partnered with Beijing’s China-Japan Friendship Hospital to conduct test runs using an antiviral drug called remdesivir on coronavirus patients in Wuhan. 

Researchers say that the combined effort in finding a vaccine for COVID-19 is one of the quickest responses in recent history. The severe acute respiratory syndrome (SARS) outbreak in 2002–2003 saw researchers spend more than 20 months to find an experimental vaccine.

[article_ad]

Related

Tags: North AmericaShort read
ShareTweetShare

Latest Posts

Juul banned

The US orders Juul vapes off the market. Here’s what you need to know

June 24, 2022
US gun legislation

US Senate agrees to fast-track new gun law

June 23, 2022
January 6 hearings

The fourth day of the January 6 hearings show Trump’s pressure campaign on election officials

June 22, 2022

Senator Ron Wyden proposes a tax increase on price-gouging oil companies

June 15, 2022

US House of Representatives holds primetime TV hearings on the January 6 attack on the Capitol. Here’s what you need to know

June 13, 2022

Biden to travel to Saudi Arabia this month to alleviate oil prices as OPEC+ increases production

June 3, 2022

Texas shooting: 21 people confirmed dead; Biden says he’s “sick and tired” of US gun violence

May 26, 2022

The US SEC investigates Wall Street over use of unapproved messaging apps

May 19, 2022

There is a “very, very high risk” of a US recession, says Goldman Sachs Chairman Lloyd Blankfein

May 17, 2022

SUBSCRIBE TO THE TMS NEWSLETTER

By providing your email, you agree to our Privacy Policy

The Millennial Source Ltd. 2021

No Result
View All Result
  • Your daily briefing
  • About us
  • Explore
    • Startups
    • Climate change
    • Tech giants
    • Crypto
    • The future of work
    • Banking giants
    • Economy
  • Lifestyle
  • Human stories
  • TMS archives
  • Write for us
  • Contact
  • Privacy Policy & Terms

2022 The Millennial Source Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 

Loading Comments...
 

    string(24) "jsonld single post debug"
    The Millennial Source
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.